Skip to main content
. 2013 Aug 12;2013:301549. doi: 10.1155/2013/301549

Table 5.

Factors associated with continuing (vs. starting, stopping, or never using) self-care and practitioner-based CAM among women in the LIBCSP, multivariable analyses, OR (95% Confidence Interval).

Multivitaminsb Single vitamins/mineralsb Botanicalsb Other dietary supplementsb Mind-bodyb Special dietsb Prayerb Support groupsb CAM practitionersb
Agea
 Continuous 0.98 (0.95–1.00) 1.01 (0.98–1.04) 1.00 (0.98–1.03) 0.98 (0.94–1.02) 1.00 (0.97–1.04) 1.00 (0.97–1.03) 0.97 (0.94–1.00) 1.01 (0.93–1.08) 0.99 (0.96–1.02)
Racea
 Non-Hispanic white 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 All Other 0.78 (0.39–1.60) 1.09 (0.50–2.35) 0.60 (0.26–1.36) 0.40 (0.10–1.62) 1.89 (0.80–4.49) 2.18 (1.05–4.53) 1.10 (0.52–2.32) 1.74 (0.30–10.11) 0.95 (0.40–2.22)
Annual household incomea
 <$25k 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 $25k–$49,999 1.14 (0.60–2.14) 2.37 (1.21–4.64) 1.38 (0.64–2.98) 0.38 (0.13–1.10) 0.78 (0.33–1.83) 0.56 (0.26–1.19) 1.79 (0.86–3.72) 0.76 (0.34–1.72)
 $50k–$89,999 0.97 (0.50–1.91) 2.61 (1.28–5.30) 1.12 (0.50–2.50) 0.40 (0.13–1.19) 0.50 (0.20–1.25) 0.73 (0.33–1.59) 1.38 (0.64–2.97) 0.79 (0.34–1.82)
 ≥$90k 0.87 (0.42–1.82) 2.09 (0.96–4.55) 1.11 (0.47–2.60) 0.31 (0.10–1.01) 0.45 (0.16–1.21) 0.96 (0.42–2.22) 1.00 (0.43–2.31) 0.82 (0.33–2.02)
Educationa
 ≤High school grad 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 Some college 1.25 (0.80–1.96) 1.00 (0.64–1.58) 1.82 (1.12–2.95) 0.86 (0.38–1.99) 2.38 (1.29–4.39) 1.26 (0.74–2.15) 1.02 (0.64–1.64) 0.91 (0.24–3.40) 1.26 (0.73–2.17)
 College graduate 1.17 (0.66–2.08) 1.00 (0.55–1.83) 2.72 (1.49–4.95) 2.17 (0.88–5.39) 1.36 (0.60–3.08) 1.25 (0.65–2.42) 0.76 (0.41–1.41) 1.31 (0.29–5.98) 1.83 (0.96–3.51)
 Postgraduate 0.85 (0.50–1.45) 1.12 (0.64–1.96) 2.25 (1.28–3.95) 2.60 (1.13–5.97) 2.44 (1.20–4.99) 1.07 (0.58–1.98) 0.80 (0.45–1.42) 0.73 (0.17–3.14) 1.54 (0.83–2.84)
BMI at diagnosisa
 <25 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 25–29 0.79 (0.53–1.17) 1.10 (0.73–1.66) 1.00 (0.66–1.52) 0.74 (0.39–1.40) 0.53 (0.30–0.91) 1.21 (0.77–1.90) 0.96 (0.63–1.47) 0.74 (0.21–2.63) 1.58 (0.99–2.53)
 ≥30 0.78 (0.48–1.25) 0.76 (0.46–1.26) 0.58 (0.34–1.01) 0.40 (0.17–0.98) 0.76 (0.40–1.46) 1.11 (0.63–1.97) 1.27 (0.76–2.10) 1.90 (0.58–6.21) 2.52 (1.44–4.43)
Menopausal (meno.) statusa
 Premeno. 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 Postmeno. 1.34 (0.80–2.24) 0.86 (0.50–1.47) 0.94 (0.55–1.61) 2.81 (1.27–6.24) 0.94 (0.48–1.84) 0.98 (0.54–1.78) 1.03 (0.60–1.77) 0.70 (0.18–2.74) 0.66 (0.37–1.18)
Mammograma
 Never/>5 yrs ago 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 <5 yrs ago 0.85 (0.52–1.37) 1.95 (1.13–3.38) 1.10 (0.64–1.91) 2.26 (0.64–7.92) 1.43 (0.61–3.34) 2.01 (0.76–5.32) 1.09 (0.65–1.82) 0.85 (0.24–3.04) 0.70 (0.41–1.19)
Physical activity (h/wk)a
 0 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 0–0.69 1.41 (0.87–2.30) 0.68 (0.41–1.12) 1.51 (0.87–2.61) 1.30 (0.55–3.05) 1.80 (0.86–3.79) 1.64 (0.90–2.97) 1.09 (0.64–1.86) 0.66 (0.14–3.04) 1.25 (0.67–2.33)
 0.70–2.6 1.50 (0.93–2.43) 1.00 (0.60–1.64) 1.17 (0.68–2.01) 1.26 (0.56–2.84) 1.70 (0.82–3.50) 0.95 (0.52–1.73) 1.12 (0.67–1.89) 1.49 (0.39–5.73) 1.28 (0.71–2.32)
 ≥2.7 1.31 (0.80–2.14) 1.13 (0.68–1.90) 1.46 (0.85–2.50) 0.97 (0.42–2.22) 2.44 (1.20–4.97) 1.38 (0.76–2.48) 0.98 (0.57–1.68) 0.67 (0.14–3.13) 1.54 (0.85–2.80)
Cigarette smoking statusa
 Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 Current 0.94 (0.58–1.52) 0.79 (0.48–1.31) 1.17 (0.70–1.96) 1.03 (0.46–2.32) 0.83 (0.41–1.70) 0.44 (0.23–0.87) 0.75 (0.45–1.27) 0.85 (0.16–4.63) 1.00 (0.56–1.79)
 Former 1.25 (0.85–1.84) 0.82 (0.55–1.22) 0.77 (0.51–1.17) 0.66 (0.35–1.23) 1.24 (0.75–2.06) 1.10 (0.71–1.69) 0.78 (0.51–1.18) 2.16 (0.77–6.06) 1.23 (0.78–1.94)
Alcohol usea
 Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 Ever 1.01 (0.69–1.47) 1.51 (1.03–2.22) 0.79 (0.53–1.18) 1.05 (0.56–1.99) 0.97 (0.57–1.62) 1.01 (0.65–1.56) 0.91 (0.61–1.35) 0.55 (0.20–1.54) 1.43 (0.91–2.26)
Fruit and vegetable intake (servings/ wk)a
 0–34 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
 ≥35 1.51 (1.06–2.17) 1.18 (0.81–1.71) 1.46 (1.00–2.12) 0.87 (0.49–1.55) 1.44 (0.91–2.30) 1.23 (0.82–1.84) 1.24 (0.85–1.81) 0.69 (0.25–1.94) 0.82 (0.54–1.25)
Stage at diagnosisa
 In situ (1 Ref) (1 Ref) (1 Ref) (1 Ref) (1 Ref) (1 Ref) (1 Ref) (1 Ref) (1 Ref)
 Invasive 0.80 (0.48–1.34) 1.47 (0.86–2.53) 0.66 (0.38–1.13) 0.88 (0.39–1.98) 0.99 (0.48–2.03) 0.90 (0.49–1.64) 0.93 (0.54–1.61) 0.76 (0.15–3.83) 0.73 (0.41–1.31)
Treatments receivedb
 Chemo. (no/yes) 0.82 (0.55–1.24) 0.83 (0.54–1.28) 1.92 (1.23–2.98) 1.46 (0.74–2.89) 1.51 (0.87–2.62) 1.15 (0.71–1.86) 1.06 (0.68–1.63) 2.04 (0.59–7.05) 1.08 (0.66–1.77)
 Tamoxifen (no/yes) 1.14 (0.78–1.66) 0.60 (0.40–0.89) 0.84 (0.56–1.25) 0.60 (0.33–1.09) 1.05 (0.63–1.74) 1.26 (0.81–1.96) 1.38 (0.92–2.07) 0.94 (0.33–2.63) 0.82 (0.53–1.28)
Continuous CAM Use before diagnosisb
 Multivit. N/A 3.60 (2.52–5.15) 1.85 (1.25–2.75) 1.53 (0.81–2.90) 1.63 (0.99–2.70) 0.93 (0.61–1.43) 1.43 (0.97–2.13) 1.04 (0.37–2.92) 1.05 (0.68–1.63)
 Single vit. 3.61 (2.53–5.16) N/A 1.58 (1.04–2.38) 3.87 (1.77–8.45) 0.98 (0.58–1.65) 1.74 (1.10–2.75) 1.06 (0.70–1.59) 0.82 (0.28–2.35) 2.13 (1.33–3.42)
 Botanicals 1.79 (1.21–2.66) 1.59 (1.05–2.40) N/A 0.70 (0.39–1.27) 1.13 (0.70–1.84) 1.32 (0.86–2.03) 1.69 (1.12–2.53) 1.29 (0.47–3.57) 1.73 (1.13–2.65)
 Other diet. supp. 1.38 (0.75–2.52) 3.38 (1.62–7.05) 0.75 (0.43–1.33) N/A 2.86 (1.57–5.20) 1.12 (0.62–2.04) 1.00 (0.54–1.82) 1.23 (0.32–4.65) 3.55 (2.02–6.24)
 Mind-body 1.58 (0.96–2.61) 0.98 (0.58–1.65) 1.04 (0.64–1.69) 2.64 (1.42–4.89) N/A 1.71 (1.04–2.79) 7.53 (4.50–12.62) 5.43 (1.93–15.28) 2.41 (1.48–3.94)
 Special diet 0.93 (0.60–1.43) 1.65 (1.05–2.60) 1.31 (0.85–2.01) 1.26 (0.67–2.35) 1.66 (1.01–2.74) N/A 1.24 (0.80–1.94) 1.17 (0.39–3.51) 1.55 (0.98–2.45)
 CAM practitioner 1.11 (0.72–1.71) 2.00 (1.26–3.18) 1.74 (1.14–2.66) 3.94 (2.18–7.09) 2.34 (1.42–3.85) 1.53 (0.97–2.43) 1.54 (0.99–2.39) 2.17 (0.74–6.37) N/A

aData collected at baseline, 1996-997; bData collected at follow-up, 2002–2004.

Bold text indicates statistically significant odds ratio (P < 0.05).